Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women

Cancer. 2003 Jul 15;98(2):431-2; author reply 432-3. doi: 10.1002/cncr.11499.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Breast Neoplasms / drug therapy
  • Endometrial Neoplasms / chemically induced
  • Endometrial Neoplasms / diagnostic imaging*
  • Endometrial Neoplasms / pathology
  • Estrogen Antagonists / adverse effects*
  • Estrogen Antagonists / therapeutic use
  • Female
  • Humans
  • Hysteroscopy
  • Postmenopause
  • Tamoxifen / adverse effects*
  • Tamoxifen / therapeutic use
  • Ultrasonography

Substances

  • Estrogen Antagonists
  • Tamoxifen